[en] Background: Poor quality antimalarial medicines still represent a threat to the public health, especially in Sub-Saharan Africa which bears a disproportionate share of the global burden of malaria. It is essential and urgent to strengthen mechanisms against counterfeit medicines. One of the approaches is regular market surveillance through quality controls.
Methods: 12 samples of artemether/lumefantrine were collected from formal and informal drug sellers in Cotonou (Benin) as well as additional other similar samples from Rwanda (13 samples) and from D.R. Congo (9 samples). Thin Layer Chromatography (TLC) as classical and simple identification test was applied in Benin while an analytical chemistry laboratory in Belgium (ULg, Pharmacy Department) was asked for further analyses with HPLC and Raman spectroscopy using a developed and validated HPLC method for rapid analysis of artemether/lumefantrine.
Results: The results obtained in Belgium confirmed the lack of the two active ingredients in the suspected sample of ACT medicine from Benin whereas some samples from Rwanda and D.R. Congo were found to present risk of substandard drugs either for under-dosing or over-dosing.
Conclusions: Counterfeit/falsified of artemisinin-based combination therapy (ACT) medicines are really scourge that needs to be fought through strong collaboration between public health authorities and appropriate quality control laboratories.
Research center :
Centre Interfacultaire de Recherche du Médicament - CIRM
World Health Organization World Malaria Report 2015; Geneva:WHO Press 2015, 244.
Newton PN, Dondorp A, Green M, Mayxay M, White NJ. Counterfeit artesunate antimalarials in southeast asia. Lancet 2003; 362: 169.
Kaur H, Allan EL, Mamadu I, et al. Quality of artemisinin based combination formulations for malaria treatment: prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in enugu, nigeria. PLoS One 2015; 10(5): e0125577.
Habyalimana V, Kalenda Tshilombo N, Dispas A, et al. Méthodes chromatographiques génériques de criblage pour lutter contre les médicaments de qualité inférieure. Spectra Analyse 2014, 298: 30-6.
Mbinze JK, Yemoa A, Lebrun P, et al. Fighting poor quality medicines:development, transfer and validation of generic hplc methods for analyzing two who recommended antimalarial tablets. Amer J Analyt Chem 2015; 6: 127-44.
National Institute of Statistics and Economic Analysis, Sanitary Enterprises in Benin: Thematic report 2010, Benin; 61.
World Health Organization (WHO), Counterfeit Drugs: Guidelines for the Development of Measures to Combat Counterfeit Drugs, WHO Press 1999, 59 p from http://apps.who.int/medicinedocs/pdf/h1456e/h1456e.pdf [cited: 10th Fev 2017].
Habyalimana V, Mbinze JK, Tshilombo NK, et al. Analytical tools and strategic approach to detect poor quality medicines, identify unknown components, and timely alerts for appropriate measures:Case study of antimalarial medicines. Amer J Analyt Chem 2015; 6: 977-94.
US Pharmacopeia, 2014; USP 37-NF 32 on line. Available at http://www.uspnf.com/notices/correction-usp-37-nf-32-secondsupplement-and-usp-38-nf-33-online-publications
International Pharmacopeia, 2015; WHO; Fifth Edition on line. Available at http://apps.who.int/phint/en/p/about/
Eilers PHC. Parametric time warping. Anal Chem 2004; 76(2): 404-11.
Jaumot J, Gargallo R, de Juan A, Tauler R. A graphical userfriendly interface for MCR-ALS: a new tool for multivariate curve resolution in MATLAB. Chemometr Intell Lab Syst 2005; 76: 101-10.
Akole C. The Fight against counterfeit drugs: quality control of drugs pilot study of benin illicit market. Pharmacy Doctoral Thesis dissertation. Benin: National University of Benin; 2010.
Visser BJ, Meerveld-Gerrits J, Kroon D, et al. Assessing the quality of anti-malarial drugs from Gabonese pharmacies using the MiniLab®: A field study. Malar J 2015; 14: 273.
http://www.iracm.com/en/2013/05/falsified-batches-of-coartemrecently-circulating-in-western-and-central-africa/ [accessed on 11 February, 2017.]
World Health Organization (WHO), Survey of the quality of selected antimalarial medicines circulating in six countries of sub-Saharan Africa; Geneva: WHO Press 2011; 118.
Risha PG, Msuya Z, Clark M, et al. The use of minilabs to improve the testing capacity of regulatory authorities in resource limited settings:Tanzanian experience. Health Policy 2008; 87: 217-22.
